Market Tracker

08/28 6:01pm ET

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

4.70
Delayed Data
As of Aug 28
 +0.10 / +2.17%
Today’s Change
4.25
Today|||52-Week Range
12.88
-49.95%
Year-to-Date
No recent news for Pernix Therapeutics Holdings Inc.

Today’s Trading

Previous close4.60
Today’s open4.57
Day’s range4.57 - 4.74
Volume563,966
Average volume (3 months)1,249,925
Market cap$286.9M
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)-32.86%
Earnings growth (this year)-79.93%
Earnings growth (next 5 years)+13.60%
Revenue growth (last year)+43.45%
P/E ratioNM
Price/Sales2.92
Price/Book2.16

Competitors

 Today’s
change
Today’s
% change
CCXIChemoCentryx Inc-0.39-5.66%
POZNPOZEN Inc+0.02+0.23%
SNTASynta Pharmaceutical...+0.08+4.04%
ANTHAnthera Pharmaceutic...-0.14-1.85%
Data as of 3:59pm ET, 08/28/2015

Financials

Next reporting dateNovember 10, 2015
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$121.7M
Annual profit (last year)-$35.3M
Net profit margin-28.98%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Douglas L. Drysdale
Chief Operating Officer
Terence S. Novak
Corporate headquarters
Morristown, New Jersey

Forecasts